Clinical Trials
3 trialsNCT03310541 2023-05-06
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00476645 2014-08-05
Fulvestrant in Hormone Refractory Prostate Cancer
Stanford University
Phase 2 Completed
NCT00244998 2013-03-08
Fulvestrant in Treating Patients With Advanced Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Completed